Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Gains from Sales and Divestitures (2022 - 2026)

Lucid Diagnostics filings provide 3 years of Gains from Sales and Divestitures readings, the most recent being $26912.0 for Q4 2024.

  • On a quarterly basis, Gains from Sales and Divestitures fell 91.15% to $26912.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $26912.0, a 91.15% decrease, with the full-year FY2024 number at $26912.0, down 91.15% from a year prior.
  • Gains from Sales and Divestitures hit $26912.0 in Q4 2024 for Lucid Diagnostics, roughly flat from $26912.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $303980.0 in Q4 2023 to a low of $26912.0 in Q1 2024.
  • Median Gains from Sales and Divestitures over the past 3 years was $50000.0 (2023), compared with a mean of $106958.8.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 79.53% in 2023 and later tumbled 91.15% in 2024.
  • Lucid Diagnostics' Gains from Sales and Divestitures stood at $169320.0 in 2022, then soared by 79.53% to $303980.0 in 2023, then tumbled by 91.15% to $26912.0 in 2024.
  • The last three reported values for Gains from Sales and Divestitures were $26912.0 (Q4 2024), $26912.0 (Q3 2024), and $26912.0 (Q2 2024) per Business Quant data.